These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 2468868
41. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial. Ruzyllo W, Tendera M, Ford I, Fox KM. Drugs; 2007; 67(3):393-405. PubMed ID: 17335297 [Abstract] [Full Text] [Related]
42. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment. Frishman W, Charlap S, Kimmel B, Teicher M, Cinnamon J, Allen L, Strom J. Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158 [Abstract] [Full Text] [Related]
43. A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects. Lam J, Chaitman BR, Crean P, Blum R, Waters DD. J Am Coll Cardiol; 1985 Aug; 6(2):447-52. PubMed ID: 3894474 [Abstract] [Full Text] [Related]
44. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine. Di Somma S, de Divitiis M, Bertocchi F, Carotenuto A, Cudemo G, Petitto M, Napodano M, de Divitiis O. Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181 [Abstract] [Full Text] [Related]
45. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study. Ulvenstam G, Diderholm E, Frithz G, Gudbrandsson T, Hedbäck B, Höglund C, Moelstad P, Perk J, Sverrisson JT. J Cardiovasc Pharmacol; 1992 Jul; 20 Suppl 3():S67-73. PubMed ID: 1282179 [Abstract] [Full Text] [Related]
46. Increased exercise tolerance and reduced electrocardiographic ischaemia 3 and 12 hours after oral felodipine in effort angina. Verdecchia P, Gatteschi C, Benemio G, Guerrieri M, Boldrini F, Pollavini G, Porcellati C. Eur Heart J; 1989 Jan; 10(1):70-6. PubMed ID: 2702968 [Abstract] [Full Text] [Related]
47. Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. Pepine CJ, Cooper-DeHoff RM, Weiss RJ, Koren M, Bittar N, Thadani U, Minkwitz MC, Michelson EL, Hutchinson HG, Comparative Efficacy and Safety of Nisoldipine and Amlodipine (CESNA-II) Study Investigators. Am J Cardiol; 2003 Feb 01; 91(3):274-9. PubMed ID: 12565082 [Abstract] [Full Text] [Related]
48. Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris. Sheridan JV, Thomas P, Routledge PA, Sheridan DJ. Br J Clin Pharmacol; 1987 Apr 01; 23(4):391-6. PubMed ID: 3107605 [Abstract] [Full Text] [Related]
53. [The efficacy of proxodolol, a new beta-adrenoblockader with alpha-adrenoblockader properties, in its single use in patients with stable stenocardia of effort]. Metelitsa VI, Martsevich SIu, Kozyreva MP, Slastnikova ID, Vakulovskaia MK. Eksp Klin Farmakol; 1994 Apr 01; 57(3):47-50. PubMed ID: 7914121 [Abstract] [Full Text] [Related]
55. Efficacy of pentoxifylline in patients with stable angina pectoris. Insel J, Halle AA, Mirvis DM. Angiology; 1988 Jun 01; 39(6):514-9. PubMed ID: 3377271 [Abstract] [Full Text] [Related]
56. Comparison of the effects of nifedipine and nitroglycerin on hemodynamic determinants of myocardial oxygen consumption and supply during exertional angina. Choong CY, Freedman SB, Roubin GS, Shen WF, Bautovich GJ, Harris PJ, Kelly DT. J Cardiovasc Pharmacol; 1989 Mar 01; 13(3):361-9. PubMed ID: 2471880 [Abstract] [Full Text] [Related]